Krebs Biochemicals & Industries Limited (BOM:524518)
India flag India · Delayed Price · Currency is INR
75.85
+2.85 (3.90%)
At close: May 7, 2025

Krebs Biochemicals & Industries Company Description

Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India.

The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications.

The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications.

In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies.

The company was incorporated in 1991 and is based in Visakhapatnam, India.

Krebs Biochemicals & Industries Limited
Country India
Founded 1991
Industry Medicinal Chemicals and Botanical Products
Employees 191
CEO Jitendra Shah

Contact Details

Address:
Kothapalli Village
Visakhapatnam, 531031
India
Phone 91 91 2114 4984
Website krebsbiochem.com

Stock Details

Ticker Symbol 524518
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 2833

Key Executives

Name Position
Jitendra Shah Chief Executive Officer
Ritesh Jain Chief Financial Officer